Xylapan 20 mg/ml Roztwór do wstrzykiwań
Xylapan 20 mg/ml Roztwór do wstrzykiwań
Authorised
- Xylazine
Product identification
Medicine name:
Xylapan 20 mg/ml Roztwór do wstrzykiwań
Active substance:
- Xylazine
Target species:
-
Cattle
-
Horse
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine20.00milligram(s)/millilitre1.00milligram(s)/millilitre
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal0day
-
-
Horse
-
Meat and offal0day
-
-
Dog
-
Cat
-
-
Intravenous use
-
Cattle
-
Meat and offal0day
-
-
Horse
-
Meat and offal0day
-
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Package description:
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1185
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 16/03/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 26/04/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 15/11/2024
How useful was this page?: